Avadel Pharmaceuticals Plc (AVDL)
21.64
0.00 (0.00%)
USD |
NASDAQ |
Mar 03, 16:00
Avadel Pharmaceuticals Research and Development Expense (Annual) : 15.20M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Alkermes Plc | 318.36M |
| Medtronic Plc | 2.732B |
| STERIS Plc (Ireland) | 107.65M |
| Amarin Corp. Plc | 19.85M |
| Jazz Pharmaceuticals Plc | 782.74M |